A carregar...
Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival
BACKGROUND: KRAS mutations reported in non-small cell lung cancer (NSCLC) represent a significant percentage of patients diagnosed with NSCLC. However, there still remains no therapeutic option designed to target KRAS. In an era with immunotherapy as a dominant treatment option in metastatic NSCLC,...
Na minha lista:
| Publicado no: | J Thorac Dis |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7578487/ https://ncbi.nlm.nih.gov/pubmed/33145085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2020.04.18 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|